Natasha Giordano - Aug 9, 2021 Form 4 Insider Report for PLx Pharma Inc. (PLXPQ)

Role
Chief Executive Officer, Director
Signature
/s/ Natasha Giordano
Stock symbol
PLXPQ
Transactions as of
Aug 9, 2021
Transactions value $
$0
Form type
4
Date filed
8/11/2021, 09:01 AM
Next filing
Nov 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXPQ Stock Option (right to buy) Award $0 +200K $0.00 200K Aug 9, 2021 Common Stock 200K $16.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
F2 These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.